Intellia Therapeutics (NTLA) earnings, Nov 5, 2026: EPS +1%, stock −9.8%
In brief
Intellia Therapeutics reported on Nov 5, 2026. Earnings per share changed +1% year over year, 14.2% below the estimate; revenue −48%. The stock opened with a −0.4% gap and closed the day −9.8% (Nov 5, 2026). The stock is now 39.9% below its 52-week high, −18.2% over 12 months.
EPS vs estimate−14.2%
EPS, YoY+1%
Revenue, YoY−48%
Gap · day−0.4% · −9.8%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Aug 6, 2026 | +5.7% | +6.2% |
| Nov 5, 2026 | −0.4% | −9.8% |
Next-quarter estimates, ratings and the NTLA chart are in the terminal.
Open the terminalFAQ
When is Intellia Therapeutics's next earnings report?
There is no new date in the data yet: companies announce it a few weeks ahead.
How did Intellia Therapeutics stock react to the report?
Opening gap −0.4%, day's result −9.8%.
Did Intellia Therapeutics's earnings grow?
Earnings per share rose 1% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.